Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirley Wu

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Biomacromolecules|March 22, 2018
Aqueous-Soluble, Acid-Transforming Chitosan for Efficient and Stimuli-Responsive Gene SilencingJulius A Edson, Dominique Ingato, Shirley Wu, et al.
Medical Ultrasonography|September 11, 2021
Feasibility of pneumoperitoneum diagnosis using point-of-care ultrasound: a pilot study using a fresh cadaver modelMeghan Kelly Herbst, Elizabeth M Carter, Shirley Wu, et al.
Plos Computational Biology|January 31, 2009
Microblogging the ISMB: a new approach to conference reportingNeil Saunders, Pedro Beltrão, Lars Jensen, et al.
Comprehensive Psychiatry|February 5, 2008
Validation of the Patient Health Questionnaire-9 for depression screening among Chinese AmericansAlbert Yeung, Freddy Fung, Shu-Ching Yu, et al.
Cancer Letters|November 2, 2010
A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cellsFei Wang, Shumei Zhai, Xiaojun Liu, et al.
Journal of Affective Disorders|January 4, 2026
Insomnia longitudinally predicts reduced reward motivation in adults with elevated depressive symptomsShirley Wu, D Gage Jordan, Devika Goel, et al.
Plos One|December 5, 2024
Pharmacokinetic evaluation of single-dose migalastat in non-Fabry disease subjects with ESRD receiving dialysis treatment, and use of modeling to select dose regimens in Fabry disease subjects with ESRD receiving dialysis treatmentFranklin K Johnson, Shirley Wu, Ginny Schmith, et al.
Plos One|April 8, 2025
Correction: Pharmacokinetic evaluation of single-dose migalastat in non-Fabry disease subjects with ESRD receiving dialysis treatment, and use of modeling to select dose regimens in Fabry disease subjects with ESRD receiving dialysis treatmentFranklin K Johnson, Shirley Wu, Ginny Schmith, et al.
Ophthalmology. Retina|March 6, 2026
Associations Between Systemic Tyrosine Kinase Inhibitors and Development of Age-Related Macular Degeneration in Patients with CancerShirley Wu, Hejin Jeong, Hayden A Reed, et al.
JMIR Mental Health|October 6, 2018
Identifying the Underlying Factors Associated With Patients' Attitudes Toward Antidepressants: Qualitative and Quantitative Analysis of Patient Drug ReviewsMaryam Zolnoori, Kin Wah Fung, Paul Fontelo, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Biomacromolecules|March 22, 2018
Aqueous-Soluble, Acid-Transforming Chitosan for Efficient and Stimuli-Responsive Gene SilencingJulius A Edson, Dominique Ingato, Shirley Wu, et al.
Medical Ultrasonography|September 11, 2021
Feasibility of pneumoperitoneum diagnosis using point-of-care ultrasound: a pilot study using a fresh cadaver modelMeghan Kelly Herbst, Elizabeth M Carter, Shirley Wu, et al.
Plos Computational Biology|January 31, 2009
Microblogging the ISMB: a new approach to conference reportingNeil Saunders, Pedro Beltrão, Lars Jensen, et al.
Comprehensive Psychiatry|February 5, 2008
Validation of the Patient Health Questionnaire-9 for depression screening among Chinese AmericansAlbert Yeung, Freddy Fung, Shu-Ching Yu, et al.
Cancer Letters|November 2, 2010
A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cellsFei Wang, Shumei Zhai, Xiaojun Liu, et al.
Journal of Affective Disorders|January 4, 2026
Insomnia longitudinally predicts reduced reward motivation in adults with elevated depressive symptomsShirley Wu, D Gage Jordan, Devika Goel, et al.
Plos One|December 5, 2024
Pharmacokinetic evaluation of single-dose migalastat in non-Fabry disease subjects with ESRD receiving dialysis treatment, and use of modeling to select dose regimens in Fabry disease subjects with ESRD receiving dialysis treatmentFranklin K Johnson, Shirley Wu, Ginny Schmith, et al.
Plos One|April 8, 2025
Correction: Pharmacokinetic evaluation of single-dose migalastat in non-Fabry disease subjects with ESRD receiving dialysis treatment, and use of modeling to select dose regimens in Fabry disease subjects with ESRD receiving dialysis treatmentFranklin K Johnson, Shirley Wu, Ginny Schmith, et al.
Ophthalmology. Retina|March 6, 2026
Associations Between Systemic Tyrosine Kinase Inhibitors and Development of Age-Related Macular Degeneration in Patients with CancerShirley Wu, Hejin Jeong, Hayden A Reed, et al.
JMIR Mental Health|October 6, 2018
Identifying the Underlying Factors Associated With Patients' Attitudes Toward Antidepressants: Qualitative and Quantitative Analysis of Patient Drug ReviewsMaryam Zolnoori, Kin Wah Fung, Paul Fontelo, et al.
Pageof 5